Siluria Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Siluria Technologies, Inc. has 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include GEMINI and SILURIA. The portfolio includes 2 registered trademarks. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 1 (Chemicals). This trademark owner is based in San Francisco, CA.
409 Illinois Street
San Francisco, CA 94158
Showing of trademarks Trademarks
Trademark Classifications
Siluria Technologies, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does Siluria Technologies, Inc. have?
Siluria Technologies, Inc. has 22 U.S. trademarks filed with the USPTO. Of these, 2 registered, 20 abandoned.
What trademark classes does Siluria Technologies, Inc. file in?
Siluria Technologies, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 4 (Lubricants & Fuels). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Siluria Technologies, Inc.'s most well-known trademarks?
Siluria Technologies, Inc.'s registered trademark portfolio includes well-known marks such as GEMINI and SILURIA. These are among 2 currently registered trademarks in the portfolio.
What is Siluria Technologies, Inc.'s trademark registration success rate?
Siluria Technologies, Inc. has a 9% trademark registration rate, with 2 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.